Infinimmune Appoints Tim Sullivan, Ph.D., as Chief Business Officer
Slice of Healthcare Team
Sep 09, 2024
Key Highlights
- Tim Sullivan, Ph.D. appointed as Chief Business Officer at Infinimmune.
- Sullivan to lead corporate and business development, strategic planning.
- Brings decades of experience from roles at Spring Discovery, Arcus Biosciences, and Pfizer.
- Infinimmune is pioneering fully human antibody therapies.
Source: Business Wire
Notable Quotes
“ We’re thrilled to have Tim lead Infinimmune’s business development efforts, driving strategic growth initiatives and fostering key partnerships to advance our mission of developing fully human antibody therapies. ”
Wyatt McDonnell, CEO & Co-Founder at Infinimmune
“ I am excited to join Infinimmune at such a dynamic time. The company’s commitment to pioneering advances in antibody development is truly inspiring, and I look forward to contributing to its continued success by leading our business development initiatives. ”
Tim Sullivan, Ph.D., Chief Business Officer at Infinimmune
